Ana Belen Romero

Learn More
OBJECTIVE To compare the effectiveness of switching to rituximab (RTX) with switching to alternative tumour necrosis factor (TNF) antagonists in patients with rheumatoid arthritis (RA) failing on TNF(More)
  • 1